Patient-Reported Outcomes with Insulin Glargine 300 U/mL in People with Type 2 Diabetes: The MAGE Multicenter Observational Study.

Colin, Ides M; Alexandre, Kathy; Bruhwyler, Jacques; Scheen, André; Verhaegen, Ann

Patient-Reported Outcomes with Insulin Glargine 300 U/mL in People with Type 2 Diabetes: The MAGE Multicenter Observational Study.

Colin, Ides M; Alexandre, Kathy; Bruhwyler, Jacques; Scheen, André; Verhaegen, Ann.

Afiliación

Colin IM; Endocrino-Diabetology Clinical Research Unit, CHR Mons-Hainaut/Groupe Jolimont, Avenue Baudouin de Constantinople 5, 7000, Mons, Belgium. Ides.Michel.COLIN@jolimont.be.
Alexandre K; Sanofi, Airport Plaza, Montreal Building, Leonardo Da Vincilaan 19, 1831, Diegem, Belgium.
Bruhwyler J; Lambda-Plus, Rue Camille Hubert 15, 5032, Gembloux, Belgium.
Scheen A; Division of Diabetes, Nutrition and Metabolic Disorders and Clinical Pharmacology Unit, CHU Liège, 4000, Liège, Belgium.
Verhaegen A; Department of Endocrinology, Diabetes and Metabolism, Antwerp University Hospital, 2650, Egedem/Antwerp, Belgium.

Diabetes Ther ; 11(8): 1835-1847, 2020 Aug.

Article en En | MEDLINE | ID: mdl-32643130

Palabras clave

Basal-bolus insulin regimen; Hypoglycemia; Insulin glargine 300 U/mL; Quality of life; Type 2 diabetes

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Observational_studies Aspecto: Patient_preference Idioma: En Revista: Diabetes Ther Año: 2020 Tipo del documento: Article País de afiliación: Bélgica Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google